Antiplatelet Therapy In Ischemic Heart Disease
December 2008, Wiley-Blackwell
- Concepts in Platelet Physiology, Function, and
- Pharmacology of Oral Antiplatelet Agents
- Pharmacology of Intravenous Antiplatelet Agents
- Clinical Use of Antiplatelet Agents in Cardiovascular
- Special Circumstances.
Each chapter in the clinical section contains an overview of
guidelines, plus specifics on medical and interventional
Clinical cardiologists, platelet biologists, and a wide range of practicing and prospective clinicians in allied fields will find this text an exceptional source of current information.
1 Platelet physiology and the role of the platelet in ischemic heart disease.
Robert F. Storey .
2 Laboratory assessment of platelet function and the effects of antiplatelet agents.
Alan D. Michelson, A.L. Frelinger .
Part II Pharmacology of Oral Antiplatelet Agents.
3 Cyclooxygenase inhibitors.
Nina Chetty Raju, John W. Eikelboom .
4 Aspirin response variability and resistance.
Wai-Hong Chen, Daniel I. Simon .
5 P2Y12 inhibitors: Thienopyridines and direct oral inhibitors.
Jean-Philippe Collet, Boris Aleil, Christian Gachet, Gilles Montalescot .
6 Thienopyridine response variability and resistance.
Udaya S. Tantry, Thomas A. Suarez, Paul A. Gurbel .
Part III Pharmacology of Intravenous Antiplatelet Agents.
7 Pharmacology of intravenous glycoprotein IIb/IIIa antagonists.
James C. Blankenship, Peter B. Berger .
8 Intravenous P2Y12 inhibitors.
Steven P. Dunn, Steven R. Steinhubl .
9 Antiplatelet effects of thrombin inhibitors and fibrinolytic agents.
Nicolai Mejevoi, Anjum Tanwir, Marc Cohen .
Part IV Clinical Use of Antiplatelet Agents in Cardiovascular Disease.
10 Antiplatelet therapy in acute coronary syndrome with ST elevation.
Christian W. Hamm .
11 Antiplatelet therapy in ST-elevation myocardial infarction.
Michelle O'Donoghue, Marc S. Sabatine .
12 Antiplatelet therapy in chronic artery disease.
Kamran I. Muhammed, Deepak L. Bhatt .
13 Antiplatelet therapy in peripheral arterial disease.
Esther S. Kim, Heather L. Gornik .
14 Clinical use of antiplatelet agents in cardiovascular disease: cerebrovascular diseases.
Larry B. Goldstein .
Part V Special Circumstances.
15 Antiplatelet therapy and coronary bypass surgery: risks and benefits.
A. Burdess, N.L. Cruden, K.A. Fox .
16 Management of antiplatelet therapy for non-cardiac surgery.
Nisheeth Goel, John F. Canales, James J. Ferguson .
17 Antiplatelet therapy and coronary stents.
Alanna Coolong, Laura Mauri
Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
- Draws from expertise of leaders in antiplatelet therapy
- Easy-to-use layout enables rapid browsing
- Edited by a member of the prestigious TIMI study group with long-standing experience in the field